Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Post by Konderoon Sep 04, 2012 4:54pm
232 Views
Post# 20316654

about Prostate Health Index... PHI...

about Prostate Health Index... PHI...

Here is what said Dr. Marc Garnick, an expert in prostate cancer at  Harvard Medical School and editor in chief of HarvardProstateKnowledge.org.

"This is really a slippery slot". Unless the PHI test can identify high-risk cancers, " It may actually  lead to a continuation of the problems of overdiagnosis and overtreatment of indolent prostate cancers that have not been shown to  be benefited by routine PSA testing".

Reference : Article by Daniel Pendick, executive Editor of Harvard Men's Health Watch, July 02 2012. In Harvard Health Publications. Harvard Medical School.

Jamais quelque chose de similaire n'a été prononçé au sujet de Progensa par un expert. We never heard such a thing by an expert about Progensa.

Fantomatus

<< Previous
Bullboard Posts
Next >>